Metraipolis › archive › dc_7e49b13f79df
Real-world use of adjuvant nivolumab among patients with esophageal and gastroesophageal junction cancer at a large integrated health system — Europe PMC PMID:41473061
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41473061
- DOI
- 10.1016/j.xjon.2025.10.003
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T07:09:38.313Z
- SHA-256 of the archived text
6be98a8d1556f7e51a297e40241a8f1cf2b1e5b0814fdedeb60aebbd4dc7ade8- Stable URL of this page
https://metraipolis.com/documento/dc_7e49b13f79df
How to cite
Real-world use of adjuvant nivolumab among patients with esophageal and gastroesophageal junction cancer at a large integrated health system — Europe PMC PMID:41473061 — Europe PMC (en), https://europepmc.org/article/MED/41473061 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7e49b13f79df (Metraipolis archive dc_7e49b13f79df, sha256 6be98a8d1556f7e51a297e40241a8f1cf2b1e5b0814fdedeb60aebbd4dc7ade8)
BibTeX
@misc{dc7e49b13f79df,
title = {Real-world use of adjuvant nivolumab among patients with esophageal and gastroesophageal junction cancer at a large integrated health system — Europe PMC PMID:41473061},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41473061},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7e49b13f79df; sha256 6be98a8d1556f7e51a297e40241a8f1cf2b1e5b0814fdedeb60aebbd4dc7ade8},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41473061. Agents can read the archived copy with the MCP tool read_document.